MediPoint: Interspinous Process Decompression Devices – APAC Analysis and Market Forecasts

MediPoint: Interspinous Process Decompression Devices – APAC Analysis and Market Forecasts

  • October 2017 •
  • 31 pages •
  • Report ID: 5103466 •
  • Format: PDF
Growing aging populations worldwide are driving the expansion of specific disease populations, including degenerative spinal diseases and disorders.

Spinal fusion is currently considered the gold standard in degenerative spine treatment, accomplishing both deformity correction and stabilization. However, sequelae associated with a successful fusion procedure have driven attention towards nonfusion technologies, which are expected to challenge the growth of spinal fusion during the forecast period.

Interspinous process decompression (IPD) devices have evolved as a minimally invasive alternative to spinal fusion and laminectomy to treat painful lumbar spinal stenosis and its symptoms, including neurogenic intermittent claudication. The implants, placed between spinous processes in the symptomatic lumbar disc levels, are designed to limit painful extension of the spine while allowing neutral and flexed positions by increasing the interspinous distance with indirect decompression of the dural sac and nerve roots.

This report focuses on the market outlook for IPD products in Asia-Pacific (APAC: Australia, China, India, Japan, New Zealand, South Korea, and Taiwan). The analysis discusses the major drivers and barriers of adoption, and provides an in-depth understanding of the future outlook for this market by segment and geography.

Key Questions Answered in This Report:
- What is the current and future IPD market outlook in the developed and emerging markets? What trends are affecting the APAC market?
- Which are the key, high growth markets that IPD manufacturers should expand into? Which markets are growing the fastest, and what are the top-selling products in each segment?
- What are the unmet needs with the current generation of IPD products? How will emerging technologies fulfill these unmet needs?
- What clinical factors and technical specifications influence a physician to use one type of device over another? What is physician perception and market outlook for IPD?
- What are the challenges and complications that have hindered widespread adoption?
- With developing the next-generation of devices, what aspects of the technology are device manufacturers focused on optimizing? How will new entrants impact the IPD market?

Companies Mentioned
Globus Medical, Medtronic, Paradigm Spine, Vertiflex